Evidence map›Paper›PMID 25504153›Full record

ArticleInsights into imaging2015

Imaging spectrum of renal oncocytomas: a pictorial review with pathologic correlation.

Kousei Ishigami, Aaron R Jones, Laila Dahmoush, Leandro V Leite, Marius G Pakalniskis, Thomas J Barloon

Open access · goldAbstract read
In one paragraph

Article in Insights into imaging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The value ofCanadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kousei IshigamiDepartment of Radiology, University of Iowa Hospitals and Clinics, 3885 JPP, 200 Hawkins Drive, Iowa City, IA, 52242, USA, Ishigamikousei@aol.com.
Aaron R Jones
Laila Dahmoush
Leandro V Leite
Marius G Pakalniskis
Thomas J Barloon
University of Iowa Hospitals and Clinics · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe purpose of this pictorial review is to present the imaging spectrum of renal oncocytomas with radiological-pathological correlation.

conclusionThe differences in tumour cellularity (high cellularity or low cellularity with abundant stroma) and haemorrhagic/cystic change contribute to a wide spectrum of imaging findings of renal oncocytomas. Imaging findings substantially overlap those of common subtypes of clear cell and non-clear cell renal cell carcinomas. Multifocal renal oncocytomas are not rare, and making the diagnosis of oncocytoma with concomitant renal cell carcinoma is difficult. In addition, renal oncocytomas that demonstrate interval growth or develop in the setting of end-stage renal disease may be mistaken for malignancy. TEACHING POINTS: • High cellular components demonstrate avid arterial enhancement and subsequent washout. • Low cellular components demonstrate gradual subsequent enhancement owing to abundant stroma. • Cystic and hemorrhagic changes may account for lesion heterogeneity in the delayed phase. • Multifocal oncocytomas and oncocytomas coexisting with renal cell carcinoma are not rare. • Renal oncocytomas may demonstrate interval growth.

Identifiers

PMID25504153
PMCPMC4330236
OpenAlexW2042939619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.